Abbott And Teva Settle Fight Over Biaxin
Teva Pharmaceuticals USA and Abbott Laboratories have settled a patent infringement lawsuit over the marketing of a generic version of Abbott's extended-release antibiotic Biaxin....To view the full article, register now.
Already a subscriber? Click here to view full article